2026 HBA Woman of the Year: Dr. Aradhana Sarin
“Being named the HBA Woman of the Year is an extraordinary honor. This recognition reflects the collective work of colleagues, mentors, and teams who have supported, challenged, and inspired me. It reinforces our responsibility to champion diverse leadership and create opportunities for the next generation of women. Together, we can shape an environment where women thrive and transform the healthcare ecosystem to benefit patients. I’m grateful to be part of this movement and committed to driving progress with urgency and purpose.”
– Dr. Aradhana Sarin
Dr. Aradhana Sarin, Executive Director and Chief Financial Officer of AstraZeneca, is recognized as the 2026 HBA Woman of the Year for her transformative leadership at the intersection of science, finance, and global healthcare innovation. With more than 25 years of experience spanning clinical practice, global finance, and biopharmaceutical leadership, Dr. Sarin brings a unique perspective to advancing patient access, scientific innovation, and sustainable growth.
At AstraZeneca, Aradhana has guided strategic expansion, strengthened investment in research and development, and fostered global innovation while ensuring long-term value creation. Her prior leadership roles include CFO of Alexion Pharmaceuticals as well as senior positions at Citi, UBS, and J.P. Morgan, where she advised more than 100 healthcare transactions spanning mergers, acquisitions, and financing.
Beyond her business achievements, Dr. Sarin champions representative leadership and talent development at all levels, supporting initiatives that empower future leaders and expand access to healthcare worldwide. Her career, which spans clinical work in India and Africa as well as leadership roles on Wall Street and in global biopharma, exemplifies the HBA’s focus on creating leaders for life while driving meaningful improvements in patient outcomes around the world.
Other appointments: Aradhana is on the Board of Governors of the American Red Cross and is an Independent Director and Audit Committee member of Anheuser-Busch InBev.